Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Englitazone mechanism of antidiabetic activity studied in vitro

July 15, 1997

Gamma-pyrones for osteoporosis isolated from plant extract by Sumitomo Metal

July 14, 1997

Ergo Science's Ergoset enters phase II/III trials in obesity

July 14, 1997

U.S. patent covers obesity gene discovered by Millennium

July 14, 1997

Low cholesterol levels contribute to increased mortality

July 14, 1997

TPO binding dynamics determined in vivo in mice

July 14, 1997

Novavax's Estrasorb reduces hot flashes by up to 98% in postmenopausal women

July 11, 1997

Hematopoiesis-stimulating compounds from SmithKine Beecham and Nycomed

July 11, 1997

Natural products for hyperlipidemia

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...